Marianne Tang Severinsen
Overview
Explore the profile of Marianne Tang Severinsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
567
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maksten E, Morch C, Jakobsen L, Kragholm K, Blindum P, Simonsen M, et al.
Support Care Cancer
. 2025 Feb;
33(3):225.
PMID: 40011273
Purpose: To assess and describe chemotherapy-induced peripheral neuropathy (CIPN), a well-known complication to cancer treatment, using different methodologies in hematological patients. Methods: Patients scheduled for treatment with vincristine, bortezomib, or...
2.
Simonsen M, Maksten E, Jakobsen L, Severinsen M, Dann E, Frederiksen H, et al.
Clin Epidemiol
. 2025 Jan;
17:19-25.
PMID: 39872603
Purpose: This nationwide Danish cohort study compared overall survival (OS) between non-Western immigrant patients and Danish-born patients with lymphoma in Denmark. Furthermore, differences in clinical and socioeconomic variables were compared,...
3.
Nielsen N, Jensen J, Baech J, Trab T, El-Galaly T, Schollkopf C, et al.
Lancet Reg Health Eur
. 2025 Jan;
50():101204.
PMID: 39844882
Background: Second primary malignancies (SPMs) are a well-known, long-term complication of antineoplastic treatment. This nationwide cohort study examined the risk of non-myeloid SPMs in survivors of adult acute myeloid leukaemia...
4.
Madsen M, Moller J, Ebbehoj N, Nielsen F, Severinsen M, Jensen J, et al.
Int J Hyg Environ Health
. 2025 Jan;
264:114522.
PMID: 39836987
Background: Per- and poly-fluoroalkyl Substances (PFAS) have been used for decades in countless households and industrial products. Many PFAS do not degrade and are thus ubiquitous in the environment and...
5.
Jorgensen M, Ovlisen A, Jensen J, El-Galaly T, Dalager M, Vestergaard H, et al.
Eur J Epidemiol
. 2025 Jan;
40(1):43-53.
PMID: 39751701
Mastocytosis is a group of rare heterogeneous diseases with a prevalence previously found to be 10-23 per 100,000 persons. More awareness and improvements in the diagnostic methods in later years...
6.
Kristensen D, Jatun T, Simonsen M, Toft N, Dimitrijevic A, Orskov A, et al.
Eur J Cancer
. 2024 Sep;
212:114338.
PMID: 39326288
Background: Previous studies have shown continuous improved overall survival (OS) up to 2015 for young adults with acute lymphoblastic leukaemia (ALL). However, recently several important advances have been made justifying...
7.
Baech J, Jakobsen L, Simonsen M, Severinsen M, Frederiksen H, Niemann C, et al.
Eur J Epidemiol
. 2024 Jul;
39(8):881-892.
PMID: 38963616
Overall survival (OS) for patients with a hematological cancer may differ between immigrant and Danish-born patients due to disparities in socioeconomic status, health literacy, and language proficiency. This cohort study...
8.
Overvad T, Severinsen M, Johnsen S, Madsen S, Kannik K, Stenfeldt L, et al.
Thromb Res
. 2024 Jul;
241:109074.
PMID: 38959580
Introduction: Hospital discharge diagnoses from administrative registries are frequently used in studies of cancer-associated venous thromboembolism, but the validity of International Classification of Diseases (ICD) codes for identifying such events...
9.
Metformin use and risk of myeloproliferative neoplasms: a Danish population-based case-control study
Kristensen D, Ovlisen A, Jakobsen L, Severinsen M, Hannig L, Starklint J, et al.
Blood Adv
. 2024 May;
8(16):4478-4485.
PMID: 38758071
Previous studies have suggested that metformin has beneficial effects beyond its glucose-lowering properties, particularly in terms of its potential as an antineoplastic and cancer-preventive agent. In this study, we aimed...
10.
Roed M, Severinsen M, Maksten E, Jorgensen L, Enggaard H
J Cancer Surviv
. 2024 May;
PMID: 38743186
Purpose: To explore haematological cancer survivors' experience of chemotherapy-induced peripheral neuropathy (CIPN) in everyday life. Methods: Data were generated by means of individual semi-structured interviews with 12 haematological cancer survivors...